文献速递临床试验与 GCP

微创大范围肝手术中肝实质切开阶段高与低气腹压力对比(PPULS):一项非劣效性、多中心、随机对照试验

High versus low pneumoperitoneum PressUre for parenchymal transection in minimally invasive major liver surgery (PPULS)-a non-inferiority, multicenter, randomized, controlled trial.
PubMed 文献 · Trials · 2025-12-01

该试验计划纳入择期微创肝切除成人患者,随机分为低气腹压力(≤10 mmHg)或高气腹压力(≥14 mmHg)组,在肝实质切开阶段进行比较。每组样本量66例。主要终点为肝实质切开阶段术中出血量,次要终点包括CO2栓塞、术中组织损伤、手术时间、并发症、死亡率和住院时长。

要点

  • 低气腹压力(≤10 mmHg)可能降低CO2栓塞风险,高气腹压力(≥14 mmHg)可能减少术中出血。
  • 每组计划样本量66例,主要终点为肝实质切开阶段术中出血量。
  • 该试验旨在评估低气腹压力在肝实质切开阶段相对于高气腹压力的非劣效性。

核心结论

  • 该试验旨在评估微创肝切除肝实质切开阶段低气腹压力(≤10 mmHg)对比高气腹压力(≥14 mmHg)的非劣效性。

研究设计与样本

  • 随机非劣效性试验,计划每组纳入66例接受择期微创肝切除的成人患者,随机分配至低气腹压力(≤10 mmHg)或高气腹压力(≥14 mmHg)组。

主要发现

  • 原文未报告试验结果。
  • 低气腹压力可降低CO2栓塞发生率,高气腹压力可减少术中出血。

关键数值与推荐

  • 主要终点为肝实质切开阶段术中出血量。
  • 次要终点包括CO2栓塞、术中组织损伤、手术时间、并发症、死亡率和住院时长。
  • 低气腹压力定义为≤10 mmHg,高气腹压力定义为≥14 mmHg。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low pneumoperitoneum pressure (LPP) lowers the incidence of CO2 embolisms in minimally invasive liver resections (MILR), while higher pneumoperitoneum pressure (HPP) reduces intraoperative blood loss. This contradiction necessitates careful pressure management especially in major liver resections where intraoperative blood loss greatly impacts postoperative outcome. METHODS: In this randomized non-inferiority trial, adults undergoing elective MILR for any indication will be recruited in alignment with inclusion and exclusion criteria. After given informed consent, eligible patients will be randomized to either low (≤10 mmHg) or high (≥14 mmHg) pneumoperitoneum pressure during parenchymal transection. Blood, peritoneal biopsies, and liver tissue will be sampled to evaluate intraoperative tissue damage. Sample size (n = 66 patients per group) is calculated based on the current literature. The primary study endpoint is intraoperative blood loss during the parenchymal transection phase. Secondary endpoints include CO2 embolisms, intraoperative tissue damage, operation time, morbidity, mortality, and duration of hospitalization. DISCUSSION: Minimizing intraoperative blood loss in MILR is a clinically relevant problem, which greatly impacts the procedure's safety and influences the patient's morbidity and mortality. HPP, exerting counter pressure to the vascular pressure, serves for bleeding control in MILR. The risk of CO2 embolism, arising from the combination of high intra-abdominal pressure and low central venous pressure, favors the use of LPP. The proposed trial aims to assess the non-inferiority of LPP compared to HPP during the parenchymal transection phase of MILR. TRIAL REGISTRATION: ClinicalTrials.gov NCT06770803. First Submitted: 2024-12-30, First Submitted that Met QC Criteria: 2025-01-07, First Posted: 2025-01-13.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Giehl-Brown E, Khajeh E, Dehne S, et al. High versus low pneumoperitoneum PressUre for parenchymal transection in minimally invasive major liver surgery (PPULS)-a non-inferiority, multicenter, randomized, controlled trial. Trials. 2025. PMID: 41327288. doi:10.1186/s13063-025-09269-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。